Figure 1.
Hypothetical survival curves of an immune checkpoint inhibitor (green line) associated with a long-term benefit compared to a standard non-immunotherapeutic agent (i.e., cytotoxic chemotherapy) (red line).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.